Healthcare Triangle is trading at $4.71, down 10.02%, with no verified company-specific catalyst identified.

  • No company-specific announcement for November 4 was found; a market research page also lists no headlines for that date.
  • The latest located company release, on November 2, described an estimated Indonesia opportunity—not contracted revenue or guidance—and does not establish a reason for the decline.
  • Major U.S. indexes were higher; no verified volume information or direct catalyst was identified.